NASDAQ: CRDL
Cardiol Therapeutics Inc Stock Ownership - Who owns Cardiol Therapeutics?

Insider buying vs selling

Have Cardiol Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CRDL insiders and whales buy or sell their stock.

CRDL Shareholders

What type of owners hold Cardiol Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Mmcap International Inc Spc13.72%15,352,317$16.43MInstitution
Tejara Capital Ltd4.59%5,130,122$5.49MInstitution
Ikarian Capital LLC2.44%2,725,000$2.92MInstitution
Citadel Advisors LLC0.73%819,904$877.30kInstitution
Boothbay Fund Management LLC0.71%794,881$850.52kInstitution
Two Sigma Investments LP0.48%534,211$571.61kInstitution
Integrity Alliance LLC0.42%465,025$497.58kInstitution
Goldman Sachs Group Inc 10.30%332,400$355.67kInstitution
Morgan Stanley0.22%250,421$267.95kInstitution
Renaissance Technologies LLC0.21%229,806$245.89kInstitution

1 of 3

CRDL vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRDL24.82%0.00%
OGI5.77%0.00%
CPIX18.43%55.87%Net BuyingNet Buying
ASRT11.68%88.32%Net Selling
CTOR15.32%80.87%

Cardiol Therapeutics Stock Ownership FAQ

Who owns Cardiol Therapeutics?

Cardiol Therapeutics (NASDAQ: CRDL) is owned by 24.82% institutional shareholders, 0.00% Cardiol Therapeutics insiders, and 75.18% retail investors. Mmcap International Inc Spc is the largest individual Cardiol Therapeutics shareholder, owning 15.35M shares representing 13.72% of the company. Mmcap International Inc Spc's Cardiol Therapeutics shares are currently valued at $15.81M.

If you're new to stock investing, here's how to buy Cardiol Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.